Abstract
Multiple sclerosis (MS) is one of the most common causes of neurological disability in young and middle-aged adults and is thought to be mediated by autoreactive T cells. Activities of adenosine deaminase (ADA) and 5′(nucleotidase (5′NT), which are involved in the differentiation and maturation of the lymphoid system, were measured in peripheral blood T cells from 21 MS patients and in 23 age and sex matched healthy controls to determine whether an association existed between these enzyme abnormalities and cellular immune functions. ADA and 5′NT activities were found significantly decreased in MS patients (P < .001 and P < .01 respectively) when compared with controls. Low levels of ADA and 5′NT activities were found irrespective of whether patients had relapsing–remitting or chronic progressive MS. These findings suggest that low levels of these enzyme activities in T cells may be related to the persistent abnormalities in T cell function in the clinical course of MS.
Similar content being viewed by others
References
J. H. Noseworthy C. Lucchinetti M. Rodriguez B. G. Weinshenker (2000) ArticleTitleMultiple sclerosis N. Engl. J. Med 343 938–952 Occurrence Handle1:STN:280:DC%2BD3cvlvF2quw%3D%3D Occurrence Handle11006371
D. A. Hafler (2004) ArticleTitleMultiple sclerosis J. Clin. Invest 113 788–794 Occurrence Handle1:CAS:528:DC%2BD2cXisVagtLw%3D Occurrence Handle15067307
M. A. Laureuzi M. Marra S. Kam-Hansen H. Link (1980) ArticleTitleOligoclonal IgG and free light chains in multiple sclerosis demonstrated by thin layer polyacrylamide gel isoelectric focusing and immunofixation Ann. Neurol 18 241–247
M. Reindl C. Linington U. Brehm R. Egg E. Dilitz F. Deisenhammer W. Poewe T. Berger (1999) ArticleTitleAntibodies against the myelin oligodendrocyte glycoprotein and the myelin basic protein in multiple sclerosis and other neurological diseases: a comparative study Brain 122 2047–2056 Occurrence Handle10545390
W. C. Wallen S. A. Houff M. Iivanainen V. P. Calabrese G. H. DeVries (1981) ArticleTitleSuppressor cell activity in Multiple sclerosis Neurology 31 668–674 Occurrence Handle1:STN:280:Bi6B387ksFw%3D Occurrence Handle6454082
N. Kurata (1995) ArticleTitleAdenosne deaminase Nippon Rinsho 53 1178–1183 Occurrence Handle1:STN:280:ByqA38njtlI%3D Occurrence Handle7602776
M. B. Aldrich M. R. Blackburn R. E. Kellems (2000) ArticleTitleThe importance of adenosine deaminase for lymphocyte development and function Biochem. Biophys. Res. Commun 272 311–315 Occurrence Handle1:CAS:528:DC%2BD3cXjs12gtbg%3D Occurrence Handle10833410
M. S. Hershfield B. S. Mitchell (1995.) Immunodeficiency diseases caused by adenosine deaminase deficiency and purine nucleoside phosphorylase deficiency C. R. Scriver A. L. Beaudet W. S. Sly D. Valle (Eds) The Molecular and Metabolic Bases of Inherited Disease McGraw-Hill New York 1725–1768
K. A. Jacobson C. Hoffmann F. Cattabeni M. P. Abbracchio (1999) ArticleTitleAdenosine-induced cell death: evidence for receptor-mediated signalling Apoptosis 4 197–211 Occurrence Handle1:CAS:528:DyaK1MXlsFeru7Y%3D Occurrence Handle14634282
S. G. Apasov M. V. Sitkovsky (1999) ArticleTitleThe extracellular versus intracellular mechanisms of inhibition of TCR-triggered activation in thymocytes by adenosine under conditions of inhibited adenosine deaminase Int. Immunol 11 179–189 Occurrence Handle1:CAS:528:DyaK1MXhsVSrs7k%3D Occurrence Handle10069416
R. H. Buckley R. I. Schiff S. E. Schiff M. L. Markert L. W. Williams T. O. Harville J. L. Roberts J. M. Puck (1997) ArticleTitleHuman severe combined immunodeficiency: genetic, phenotypic, and functional diversity in one hundred eight infants J. Pediatr 130 378–387 Occurrence Handle1:STN:280:ByiB3MjjvFU%3D Occurrence Handle9063412
S. Sasaki (1984) ArticleTitlePathogenetic significance of adenosine deaminase in autoimmune diseases Nippon Seikeigeka Gakkai Zasshi 58 219–230 Occurrence Handle1:STN:280:BiuB1M%2FpslM%3D Occurrence Handle6332160
H. Zimmermann (1996) ArticleTitleBiochemistry, localization and functional roles of ecto-nucleotidases in the nervous system Prog. Neurobiol 49 589–618 Occurrence Handle1:CAS:528:DyaK28XntVCksLw%3D Occurrence Handle8912394
M. Massaia A. Pileri M. Boccadoro A. Bianchi A. Palumbo U. Dianzani (1988) ArticleTitleThe generation of alloreactive cytotoxic T-lymphocytes requires the expression of ecto-5(nucleotidase activity J. Immunol 141 3768–3775 Occurrence Handle1:CAS:528:DyaL1MXit1WksA%3D%3D Occurrence Handle2846693
F. W. Sunderman SuffixJr. (1990) ArticleTitleThe clinical biochemistry of 5(-nucleotidase Ann. Clin. Lab. Sci 20 123–139 Occurrence Handle2183704
J. F. Salazar-Gonzalez D. J. Moody J. V. Giorgi O. Martinez-Maza R. T. Mitsuyasu J. L. Fahey (1985) ArticleTitleReduced ecto-5(-nucleotidase activity and enhanced OKT10 and HLA-DR expression on CD8 (T suppressor/cytotoxic) lymphocytes in the acquired immune deficiency syndrome: evidence of CD8 cell immaturity J. Immunol 135 1778–1785 Occurrence Handle1:CAS:528:DyaL2MXlt1Wnu7Y%3D Occurrence Handle2991373
J. N. Stolk D. G. Koning Particlede A. H. Pennings R. A. Abreu ParticleDe L. B. Putte Particlevan de A. M. Boerbooms (1999) ArticleTitleReduced purine 5(-nucleotidase activity in lymphocytes of patients with systemic lupus erythematosus: results of a pilot study Ann. Rheum. Dis 58 122–125 Occurrence Handle1:STN:280:DyaK1M3nsV2qtQ%3D%3D Occurrence Handle10343529
W. I. McDonald A. Compston G. Edan (2001) ArticleTitleRecommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis Ann. Neurol 50 121–127 Occurrence Handle1:STN:280:DC%2BD38%2FitFOhug%3D%3D Occurrence Handle11456302
S. Jain M. C. Maheshwari (1985) ArticleTitleMultiple sclerosis: Indian experience in the last thirty years Neuroepidemiology 4 96–107 Occurrence Handle1:STN:280:BimC2srjsVA%3D Occurrence Handle3913869
H. A. Messner E. A. McCulloch (1973) ArticleTitleInteracting cell populations affecting granulopoietic colony formation by normal and leukemic human marrow cells Blood 42 701–710 Occurrence Handle1:STN:280:CSuD3M3osVY%3D Occurrence Handle4518063
M. F. Greaves G. Brown (1974) ArticleTitlePurification of human T and B lymphocytes J. Immunol 112 420–423 Occurrence Handle1:CAS:528:DyaE2cXktVaisb4%3D Occurrence Handle4544194
G. Giusti (1974) Adenosine deaminase M. V. Bergmeyer (Eds) Methods of Enzymatic Analysis EditionNumber2 Academic Press New York 1092–1098
C. L. Arkesteijn (1976) ArticleTitleA kinetic method for serum 5(-nucleotidase using stabilised glutamate dehydrogenase J. Clin. Chem. Clin. Biochem 14 155–158 Occurrence Handle1:CAS:528:DyaE28Xhs1SqtL0%3D Occurrence Handle180232
S. G. Apasov M. R. Blackburn R. E. Kellems P. T. Smith M. V. Sitkovsky (2001) ArticleTitleAdenosine deaminase deficiency increases thymic apoptosis and causes defective T cell receptor signaling J. Clin. Invest 108 131–141 Occurrence Handle1:CAS:528:DC%2BD3MXkvVarsL8%3D Occurrence Handle11435465
R. W. Greene H. L. Haas (1991) ArticleTitleThe electrophysiology of adenosine in the mammalian central nervous system Prog. Neurobiol 36 329–341 Occurrence Handle1:CAS:528:DyaK3MXkvVGmsbs%3D Occurrence Handle1678539
T. W. Stone H. A. Simmonds (1991.) Clinical consequences of aberrant purine metabolism T. W. Stone H. A. Simmonds (Eds) Purines: Basic and Clinical Aspects, (11) Kluwer Academic Publishers Dordrecht
M. S. Hershfield N. M. Kredich D. R. Ownby H. Ownby R. Buckley (1979) ArticleTitleIn vivo inactivation of erythrocyte S-adenosylhomocysteine hydrolase by 2(-deoxyadenosine in adenosine deaminase-deficient patients J. Clin. Invest 63 807–811 Occurrence Handle1:CAS:528:DyaE1MXitVWktrw%3D Occurrence Handle312296
D. A. Carson T. Iizasa S. Seto C. J. Carrera M. Kubota E. H. Willis D. B. Wasson O. Kajander (1985) ArticleTitleMetabolic basis for immune dysfunction in adenosine deaminase deficiency Ann. N. Y. Acad. Sci 451 34–41 Occurrence Handle1:STN:280:BimD2srkvFY%3D Occurrence Handle3878120
X. Liu C. N. Kim J. Yang R. Jemmerson X. Wang (1996) ArticleTitleInduction of apoptotic program in cell-free extracts: requirement for dATP and cytochrome c Cell 86 147–157 Occurrence Handle1:CAS:528:DyaK28XktlGnsbY%3D Occurrence Handle8689682
N. L. Edwards E. W. Gelfand L. Burk H. M. Dosch I. H. Fox (1979) ArticleTitleDistribution of 5(-nucleotidase in human lymphoid tissues Proc. Natl. Acad. Sci. USA 7 3474–3476
L. F. Thompson J. M. Ruedi M. G. Low L. T. Clement (1987) ArticleTitleDistribution of ecto-5(-nucleotidase on subsets of human T and B Iymphocytes as detected by indirect immunofluorescence using goat antibodies J. Immunol 139 4042–4048 Occurrence Handle1:CAS:528:DyaL1cXntlGqsA%3D%3D Occurrence Handle2826576
U. Traugott S. H. Stone C. S. Raine (1979) ArticleTitleChronic relapsing experimental allergic encephalomyelitis. Correlation of circulating lymphocyte fluctuations with disease activity in suppressed and unsuppressed animals J. Neurol. Sci 41 17–29 Occurrence Handle1:STN:280:CSaC2svntFU%3D Occurrence Handle86602
V. Nikolajeva D. Eze Z. Petrina I. Muiznieks (2000) ArticleTitleTreatment of experimental autoimmune encephalomyelitis with adenylate deaminase from Penicillium lanoso-viride J. Autoimmun 14 107–113 Occurrence Handle1:STN:280:DC%2BD3c7ktlGjug%3D%3D Occurrence Handle10677241
J. P. Antel D. P. Richman M. E. Medof B. G. Arnason (1978) ArticleTitleLymphocyte function and the role of regulator cells in multiple sclerosis Neurology 28 106–110 Occurrence Handle1:STN:280:CSaD2MzkvV0%3D Occurrence Handle309564
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Vivekanandhan, S., Soundararajan, C.C., Tripathi, M. et al. Adenosine Deaminase and 5′Nucleotidase Activities in Peripheral Blood T Cells of Multiple Sclerosis Patients. Neurochem Res 30, 453–456 (2005). https://doi.org/10.1007/s11064-005-2680-6
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s11064-005-2680-6